Compositions and methods for treatment of muscular dystrophy
Abstract:
The present invention features modified human transcription factors capable of increasing utrophin expression, recombinant adeno-associated vectors for delivery of the modified human transcription factors, and methods of treating muscle diseases, including Duchenne's muscular dystrophy.
Public/Granted literature
Information query
Patent Agency Ranking
0/0